5433502022-04-012022-06-305433502022-04-012022-06-30in-bse-fin:OtherExpenses1Member5433502022-04-012022-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares543350VIJAYANOTLISTEDINE043W01024VIJAYA DIAGNOSTIC CENTRE LIMITEDEquity2022-04-012023-03-312022-08-092022-07-30INRLakhsFirst quarterSingle segmentDiagnostic Services2022-08-0912:00:002022-08-0913:20:00Not applicable2022-04-012022-06-30UnauditedConsolidated10436210002769300010713140001303280000019476000047651000141759000319601000834099000237215000023721500071537000-989200061645000017557000000001755700004770001760470001745000001070000174977000107000010203080011.711.7001.711.71. The above consolidated financial results of Vijaya Diagnostic Centre Limited (formerly known as 'Vijaya Diagnostic Centre Private Limited') ("the Company") and its subsidiaries (the Company and its subsidiaries together referred to as "the Group") have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standards ("Ind AS") prescribed under Section 133 of the Companies Act, 2013 ('the Act') read with the relevant rules thereunder, other accounting principles generally accepted in India and in terms of Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. <BR> 2. The above consolidated financial results were reviewed by the audit committee and approved by the Board of Directors in their respective meetings held on 09 August 2022. The statutory auditors have carried out limited review of the above results for the quarter ended 30 June 2022. An unmodified report has been issued by them thereon. <BR> 3. The consolidated figures for the quarter ended 31 March 2022 are the balancing figures between the audited consolidated figures in respect of the full financial year and the published unaudited year to date consolidated figures up to the third quarter ended 31 December 2021, which were subject to limited review. <BR> 4. The Group has one reportable segment (viz. Diagnostic Services) as per the requirements of Ind AS 108 "Operating Segments". <BR> 5. During the quarter ended 30 June 2022, the Company has issued 64,832 equity shares of face value of Rs. 1 each on exercise of employee stock options. <BR> 6. The Indian Parliament has approved the code on social security, 2020 ("Code") which, interalia, deals with employee benefits during employment and post employment. The code has been published in the Gazette of India. The effective date of the code is yet to be notified. The Company is in the process of evaluating the impact of the relevant provisions. <BR> 7. The results of the Group are available for investors at www.vijayadiagnostic.com, www.nseindia.com and www.bseindia.comOther Expenses319601000Remeasurement of defined benefit obligations638000638000161000